Posts

Shinyak’s Rogain Foam

Competition heats up in hair loss treatment market

Competition heats up in hair loss treatment market

Local drugmakers are increasingly competing to sell over-the-counter (OTC) drugs for hair loss treatments.

Dongkook Pharm’s Pansidil and Hyundai Pharm’s Minoxyl have been leading the market. However, three other rivals recently joined the competition with new products. They are JW Shinyak, Tai Guk Pharm, and Dong-A Pharm.

The market leader, Dongkook’s Pansidil, posted more than 6.5 billion won ($6.1 million) in accumulated sales as of the third quarter last year. The accrued ales of Hyundai Pharm’s Minoxyl stood at more than 4 billion won, leading the liquid OTC drugs.

Competition heats up in hair loss treatment market

JW Shinyak and Tai Guk Pharm aim to beat Hyundai with Minoxyl-containing products, and Dong-A, to overpower Dongkook with oral drugs.

JW Shinyak’s Rogain, an original product using Minoxidil, is likely to compete with Hyundai Pharm’s Minoxyl. For Rogain, JW Shinyak recently had an exclusive sales deal. Despite the launch in 2006, the drug sales have been sluggish due to Minoxyl’s outperformance.

JW Shinyak is seeking a turnaround by transforming the liquid of the product into a foam, improving the inconvenience that the liquid flows down to the forehead.

The user can apply the foam only in the necessary parts without the liquid falling to the face. The foam is absorbed into the scalp and dries quickly, which distinguishes it from rivals, the company said.

Tai Guk Pharm released Mobarin Gel, a gel-type product containing Minoxidil.

Like the foam-type one, the user can apply the gel directly on the scalp, and there is almost zero stickiness, Tai Guk Pharm said.

Mobarin is also easy to carry because it comes in a tube. The product comes in two versions, for female and for male, which is a strong point, the company said.

Dong-A Pharm’s Capillus capsule uses the same ingredient with Pansidil, the market leader. Capillus contains calcium pantothenate, keratin, L-cystine and double yeast. However, its efficacy and number of doses are the same with Pansidil.

The number of hair loss patients increased to 212,916 in 2016 from 203, 305 in 2012, according to the Health Insurance Review & Assessment Service (HIRA).

By age groups, hair loss was most common in people in their 30s, with 26.9 percent of them having a hair loss problem. People in their 20s came next with 25.4 percent having a hair loss, followed by those in their 40s with 23 percent.

Prescription drugs to treat hair loss include pinasteride and dutasteride.

However, people prefer OTC drugs due to concerns about adverse effects of prescription drugs such as sexual dysfunction in men and development of a deformed child in pregnant women.

Source

hair loss product research

Hair Loss & Growth Treatments and Products Market

Global Hair Loss & Growth Treatments and Products Market Report Analysis (Years 2011-2017) and Market Forecast (Years 2018-2023)

Global Hair Loss & Growth Treatments and Products market research report highlights vital frameworks of Hair Loss & Growth Treatments and Products industry that includes market favourable circumstances, objectives, tendencies, drivers, and concerns.

It also throws a light on growth rate, current and fresh news of the Hair Loss & Growth Treatments and Products market along with different crucial industrial developments, top leading Hair Loss & Growth Treatments and Products industry players, and product modernization.

Global Hair Loss & Growth Treatments and Products report covers different provisions and regions and gives the market share of Hair Loss & Growth Treatments and Products industry covering each region. Correlation between the current market tendencies and competing regions along with leading market players are covered in the Hair Loss & Growth Treatments and Products report.

Different challenging market segments of Hair Loss & Growth Treatments and Products industry are also highlighted in the report.

The report titled ‘Global Hair Loss & Growth Treatments and Products market’ quotes out basic propulsive enforcements of the Hair Loss & Growth Treatments and Products industry that will be fruitful for the end-users.

Different business patterns, cautions, and the sector structures, its purchasing benchmarks and adversities faced are also cited in the Hair Loss & Growth Treatments and Products research report.

Further, it covers the scope of the Hair Loss & Growth Treatments and Products industry, its magnitude, and application in different areas. The overall revenue produced all over the globe and division of basic products according to their types determines the entire market size of the Hair Loss & Growth Treatments and Products industry.

Global Hair Loss & Growth Treatments and Products market is principally divided into dominant marketing players, applications, product types, and leading geographical zones. Vital company details such as company profiles, product specifications, price and sale of the product, product description, and contact information of also mentioned in the report.

Hair Loss & Growth Treatments and Products market separation on the basis of geographical zones:

The Hair Loss & Growth Treatments and Products market is escalated over the globe which includes Latin America (Middle and Africa), North America (Mexico, Canada, and the USA), Asia-Pacific (Korea, Japan, China and India). Asia-Pacific countries such as India and China will show advancement in the Hair Loss & Growth Treatments and Products market thus increasing the number of job opportunities.

North America has shown a tremendous increase and technological expansion in Hair Loss & Growth Treatments and Products industry over last few decades. Other European countries including Russia, France, Germany, Italy and the UK is also covered in the Hair Loss & Growth Treatments and Products market research report.

Global Hair Loss & Growth Treatments and Products market Company Coverage (Main Products,Price, Sales Revenue, Gross Margin):

Procter & Gamble
LOreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Yanagiya
Pharma Medico
Kerafiber
Phyto
Keranique
DS Healthcare Group
EcoHerbs Global
Kaminomoto
Softto
Bawang
Zhang Guang 101

Source